FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892333721> ?p ?o ?g. }

• W2892333721 endingPage "463" @default.
• W2892333721 startingPage "457" @default.
• W2892333721 abstract "Prolonged remission (PR), defined as a 5-year consecutive period of no disease activity based on SLEDAI-2K, has been reported to be associated with a lower damage accrual over time in patients with systemic lupus erythematosus (SLE), as the consequence of a lower activity burden. Since disease activity is considered to play a role in the incidence of cardiovascular disease (CVD), we investigated the relationship, if any, between PR and the occurrence of a subsequent first CV event in patients with SLE. Out of 488 patients consecutively admitted to two tertiary Italian centers from November 1, 2000, to December 31, 2016, the 294 patients, who had been followed at least for 5 years, had not experienced any CV event at admission, and had been visited biannually during follow-up, were considered for the present study. The incidence of a first CV in patients who had achieved PR was compared with that registered in those who had not. Moreover, it was compared among PR patients subdivided into three groups: complete remission, clinical off-corticosteroids (offCR), and clinical on-corticosteroids remission (onCR). Kaplan–Meier curves and the log-rank test were used to analyze differences in event-free survival among groups. Cox regression was used to investigate disease and therapeutic features associated with the development of a first CV event. During 9 years median follow-up time, 24 (8.1%) CV events occurred. Out of the 294 patients, 126 (42.8%) had achieved PR. Kaplan–Meier analysis revealed a greater overall CV event-free rate in these patients as compared to both those with a shorter lasting remission and those who had never remitted (log-rank test χ2 = 14.43; p = 0.0001). In addition, CV outcome did not differ among PR patients, irrespectively the type of remission achieved (p > 0.05). At multivariate analysis, hydroxychloroquine therapy and PR resulted to be protective (HR 0.19; HR 0.18), while arterial hypertension and antiphospholipid positivity increased the risk of a first CV event (HR 2.61; HR 2.47). The PR, whichever the subtype, is associated with a better CV outcome and should be considered as a treat-to-target goal in the CV risk management of the lupus patient." @default.
• W2892333721 created "2018-09-27" @default.
• W2892333721 creator A5008999067 @default.
• W2892333721 creator A5014482226 @default.
• W2892333721 creator A5028651643 @default.
• W2892333721 creator A5033507551 @default.
• W2892333721 creator A5049229249 @default.
• W2892333721 creator A5055770701 @default.
• W2892333721 creator A5077213592 @default.
• W2892333721 date "2018-09-07" @default.
• W2892333721 modified "2023-09-27" @default.
• W2892333721 title "Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study" @default.
• W2892333721 cites W2018939131 @default.
• W2892333721 cites W206689509 @default.
• W2892333721 cites W2077424194 @default.
• W2892333721 cites W2081133146 @default.
• W2892333721 cites W2108905161 @default.
• W2892333721 cites W2110793425 @default.
• W2892333721 cites W2113864921 @default.
• W2892333721 cites W2114440931 @default.
• W2892333721 cites W2132678730 @default.
• W2892333721 cites W2149063533 @default.
• W2892333721 cites W2151334748 @default.
• W2892333721 cites W2156027405 @default.
• W2892333721 cites W2199189793 @default.
• W2892333721 cites W2319259714 @default.
• W2892333721 cites W2409726716 @default.
• W2892333721 cites W2510251351 @default.
• W2892333721 cites W2528462240 @default.
• W2892333721 cites W2548861133 @default.
• W2892333721 cites W2549269809 @default.
• W2892333721 cites W2555873873 @default.
• W2892333721 cites W2615390224 @default.
• W2892333721 cites W2744677632 @default.
• W2892333721 cites W2765970475 @default.
• W2892333721 cites W2802589908 @default.
• W2892333721 cites W291654120 @default.
• W2892333721 cites W32832798 @default.
• W2892333721 cites W4296981399 @default.
• W2892333721 cites W945203368 @default.
• W2892333721 doi "https://doi.org/10.1007/s10067-018-4286-9" @default.
• W2892333721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30194649" @default.
• W2892333721 hasPublicationYear "2018" @default.
• W2892333721 type Work @default.
• W2892333721 sameAs 2892333721 @default.
• W2892333721 citedByCount "26" @default.
• W2892333721 countsByYear W28923337212019 @default.
• W2892333721 countsByYear W28923337212020 @default.
• W2892333721 countsByYear W28923337212021 @default.
• W2892333721 countsByYear W28923337212022 @default.
• W2892333721 countsByYear W28923337212023 @default.
• W2892333721 crossrefType "journal-article" @default.
• W2892333721 hasAuthorship W2892333721A5008999067 @default.
• W2892333721 hasAuthorship W2892333721A5014482226 @default.
• W2892333721 hasAuthorship W2892333721A5028651643 @default.
• W2892333721 hasAuthorship W2892333721A5033507551 @default.
• W2892333721 hasAuthorship W2892333721A5049229249 @default.
• W2892333721 hasAuthorship W2892333721A5055770701 @default.
• W2892333721 hasAuthorship W2892333721A5077213592 @default.
• W2892333721 hasBestOaLocation W28923337211 @default.
• W2892333721 hasConcept C10515644 @default.
• W2892333721 hasConcept C120665830 @default.
• W2892333721 hasConcept C121332964 @default.
• W2892333721 hasConcept C126322002 @default.
• W2892333721 hasConcept C198451711 @default.
• W2892333721 hasConcept C2776912625 @default.
• W2892333721 hasConcept C2779123688 @default.
• W2892333721 hasConcept C2779134260 @default.
• W2892333721 hasConcept C3008058167 @default.
• W2892333721 hasConcept C50382708 @default.
• W2892333721 hasConcept C524204448 @default.
• W2892333721 hasConcept C61511704 @default.
• W2892333721 hasConcept C66339696 @default.
• W2892333721 hasConcept C71924100 @default.
• W2892333721 hasConcept C90924648 @default.
• W2892333721 hasConceptScore W2892333721C10515644 @default.
• W2892333721 hasConceptScore W2892333721C120665830 @default.
• W2892333721 hasConceptScore W2892333721C121332964 @default.
• W2892333721 hasConceptScore W2892333721C126322002 @default.
• W2892333721 hasConceptScore W2892333721C198451711 @default.
• W2892333721 hasConceptScore W2892333721C2776912625 @default.
• W2892333721 hasConceptScore W2892333721C2779123688 @default.
• W2892333721 hasConceptScore W2892333721C2779134260 @default.
• W2892333721 hasConceptScore W2892333721C3008058167 @default.
• W2892333721 hasConceptScore W2892333721C50382708 @default.
• W2892333721 hasConceptScore W2892333721C524204448 @default.
• W2892333721 hasConceptScore W2892333721C61511704 @default.
• W2892333721 hasConceptScore W2892333721C66339696 @default.
• W2892333721 hasConceptScore W2892333721C71924100 @default.
• W2892333721 hasConceptScore W2892333721C90924648 @default.
• W2892333721 hasIssue "2" @default.
• W2892333721 hasLocation W28923337211 @default.
• W2892333721 hasLocation W28923337212 @default.
• W2892333721 hasOpenAccess W2892333721 @default.
• W2892333721 hasPrimaryLocation W28923337211 @default.
• W2892333721 hasRelatedWork W1968524627 @default.
• W2892333721 hasRelatedWork W2010631330 @default.
• W2892333721 hasRelatedWork W2031796988 @default.

• next